A common methylenetetrahydrofolate reductase gene mutation and longevity
- 1 December 1998
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 141 (2) , 315-319
- https://doi.org/10.1016/s0021-9150(98)00154-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectPublished by American Medical Association (AMA) ,1997
- MTHFR thermolabile genotype frequencies and longevity in Northern IrelandAtherosclerosis, 1997
- Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevityAtherosclerosis, 1997
- Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.Journal of Clinical Investigation, 1996
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjectsJournal of Internal Medicine, 1994
- Vitamin status and intake as primary determinants of homocysteinemia in an elderly populationJAMA, 1993
- The odds ratio: a useful tool in neurosciences.Journal of Neurology, Neurosurgery & Psychiatry, 1989